Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The case for particle therapy.

B Jones1

  • 1Queen Elizabeth University Hospital, Birmingham B15 2TH, UK.

The British Journal of Radiology
|January 20, 2006
PubMed
Summary
This summary is machine-generated.

The UK needs to invest in advanced charged particle therapy (CPT) for cancer treatment. This advanced radiotherapy offers better outcomes and quality of life, but current facilities are limited, risking patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of an antiperspirant with emollients on foot-sweat accumulation and blister formation while walking in the heat.

Journal of the American Academy of Dermatology·1995
Same author

The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy.

International journal of radiation oncology, biology, physics·1995
Same author

Entry of microbes into the host: using M cells to break the mucosal barrier.

Current opinion in immunology·1995
Same author

Derivation of the optimum dose per fraction from the linear quadratic model.

The British journal of radiology·1995
Same author

On the nature of the mutation in the nude rat.

Trends in genetics : TIG·1995
Same author

Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

Postgraduate medical journal·1995
Same journal

Utility of High-Resolution Semiconductor Positron Emission Tomography/Computed Tomography in the Assessment of Breast Cancer Extent: Comparison with Magnetic Resonance Imaging.

The British journal of radiology·2026
Same journal

Airway Imaging Practices in Primary Ciliary Dyskinesia: A Global Survey to Guide Standardized Guidelines.

The British journal of radiology·2026
Same journal

Letter to the editor: A comment on statistical power in high-dose radiation group analysis.

The British journal of radiology·2026
Same journal

"Comparative diagnostic accuracy of dual-energy CT, diffusion-weighted MRI and chemical shift MRI in cervical lymph node metastasis in head and neck cancer".

The British journal of radiology·2026
Same journal

The Utility of Advanced Imaging in COPD: Diagnosis, Prognosis, and Treatment-introductory Editorial.

The British journal of radiology·2026
Same journal

Development of In situ Dosimetry for FLASH Proton Radiotherapy via Organic Scintillating Fibers.

The British journal of radiology·2026
See all related articles

Area of Science:

  • Oncology
  • Radiotherapy
  • Medical Physics

Background:

  • The National Health Service (NHS) faces critical decisions regarding cancer treatment infrastructure.
  • Charged Particle Therapy (CPT) offers advanced radiotherapy with precise dose deposition via protons or heavy ions, unlike conventional X-ray techniques.
  • Current UK facilities are limited to lower-energy proton therapy for specific cancers, necessitating higher energies for broader applications.

Purpose of the Study:

  • To evaluate the importance of purchasing Charged Particle Therapy (CPT) centers for cancer treatment within the UK's National Health Service (NHS).
  • To highlight the advantages of CPT over conventional radiotherapy for improved patient outcomes and quality of life.
  • To address the potential threat to UK Oncology due to the anticipated need for thousands of patients to seek CPT abroad.

Related Experiment Videos

Main Methods:

  • Analysis of the principles of Charged Particle Therapy (CPT), including Bragg Peak dose deposition.
  • Comparison of CPT's precision ('dose painting') with conventional X-ray radiotherapy.
  • Assessment of current UK CPT facility capabilities (e.g., Clatterbridge cyclotron) versus required energies for advanced treatments.

Main Results:

  • CPT allows highly selective dose delivery to tumors, minimizing damage to surrounding healthy tissues.
  • Higher energy synchrotron facilities (over 200 MeV) are required for treating deeper-seated cancers.
  • A global expansion of Particle Beam Therapy (PBT) centers indicates promising advancements in cancer cure rates and patient quality of life.

Conclusions:

  • Investing in CPT centers is crucial for the UK to provide state-of-the-art cancer care.
  • Failure to expand CPT capabilities poses a significant risk to UK oncology services, potentially requiring international referrals for thousands of patients.
  • CPT offers enhanced cancer treatment options, particularly for radioresistant tumors or those near critical organs, where conventional therapy is limited.